VIRATECH AND NEWSWIRE PRESENT UNLIMITED PRESS RELE

VIRATECH AND NEWSWIRE PRESENT UNLIMITED PRESS RELEASEDISTRIBUTION FOR MICRO SOCIAL NETWORK OWNERSViratech Corp. and Newswire Collaborate in an innovativeapproach to distribution of news and educating the public about Viratech’s opensource biotech research social network platformSTOCKTON, CALIFORNIA/November 29, 2012 /Newswire/ --Viratech Corp. (OTC: VIRA) and Newswire, announced today a new collaborativeagreement between Viratech Corp and Newswire to distribute news of Viratech’sMicro Social Network operators.  Viratechhas developed a landmark open source biotech research social network platform.Using this platform, individual and small business members of Viratech’s socialnetwork can protect the intellectual property for their biotech technology,then use Viratech’s Micro Social Network as a utility to promote and crowdfundthe research and development to produce the new technology.Newswire views Viratech’s business model (Protect, Promote,Produce) as a unique and unparalleled path to opening up the speed of newtechnology advancement. Under “Protect”, the business model shows how to protectintellectual property while the patent is pending by the use of copyright andthe creation of a copyright shell. “Promote” details how a Micro Social Network, or MSN, is used to promotesegments of the patent pending idea to attract research, knowledge and fundingpartners as members of the MSN. Once formed, the MSN is then used to “Produce”the product through crowdfunding and Viratech’s innovative approach tocompensating members for their micro social network activity and collaboration.Newswire’s role in the new collaboration agreement is in thearea of Promotion.  The collaborativeagreement provides any micro social network owner access to unlimited freepress release distribution via Newswire. This allows the individual or smallbusiness owner of the MSN to promote their idea, entice funding and developmentpartners through at unique engagement funnel, and ultimately deliver theirinnovative advancement in diagnostics or therapies to those that can benefitfrom it sooner rather than later.“Viratech believes that its open source biotech researchsocial network platform will change the landscape of intellectual propertyprotection and allow medicine to finally become open sourced,” said Dr. KevinBuckman, CEO.  “By giving small companiesenhanced intellectual property protection to recruit development partners,Viratech has streamlined the process of taking an idea and making it a reality.With the emphasis of such technologies on saving lives and improving quality oflife first, and consideration of revenue or profit second, this business modelis a direct counter to the current large pharmaceutical company approach ofstifling innovation for protection of profits.” he added.“Newswire considers it an honor and a privilege to be thepromotion outlet for such an engine that allows the development partners ofViratech Corp access to free unlimited press release distribution,” said DougBrown, president of Newsire.About Viratech Corp.Based in Stockton, California, Viratech Corp. has created anopen source biotech research and development platform, Viratech has created aunique platform leveraging the utility of social collaboration, which willallow cancer research the opportunity for the first time to become opensourced.  This is accomplished byallowing our development partners the ability to protect, promote and producetheir research in unified online collaboration hubs known as micro socialnetworks. Viratech’s open source platform has integrated several intellectualproperty tools which, by leveraging our social collaboration network, can giveour development partners a new intellectual property mechanism, which will helpin addressing the protection of Intellectual Property, promotion throughcollaboration in our protected open source platform, and commercial developmentof the products achieved through collaborative research.Using this platform, Viratech members can protect theirintellectual property, then use Viratech’s micro social network as a utility topromote and crowdfund the research and development to produce the newtechnology.About NewswireNewswire, is a social network news agency of independentjournalists.  Newswire’s intellectualproperty leverages social networking with collective search engine optimizationto give journalists the tools, credibility, and distribution they need toreport the news via a single unified voice.Newswire’s unique value proposition lies in our JournalistSocial Network.  Independent writers,bloggers, photographers, and videographers represent one of the most powerfuland overlooked search engine optimization forces on the Internet.  Newswire’s platform gives them an editorialprocess, ethics policy, and the technology they need to harness their collectivepower and distribute news via search engine placement.In addition, Newswire offers businesses unique access to ourjournalist network and technology allowing them to broadcast their message tothousands of news outlets worldwide. Newswire’s press release distribution services cater to bothsmall/medium sized businesses and large publicly traded companies.  Newswire’s distribution engine places clientnews on up to 50,000 sites throughout the web, gets news to National MediaOutlets, and targets industry specific trade publications.Forward-Looking Statements:This press release includes forward-looking statementsconcerning the future performance of our business, its operations and itsfinancial performance and condition, and also includes selected operatingresults presented without the context of accompanying financial results. Theseforward-looking statements include, among others, statements with respect toour objectives and strategies to achieve those objectives, as well asstatements with respect to our beliefs, plans, expectations, anticipations,estimates or intentions. These forward-looking statements are based on ourcurrent expectations. We caution that all forward-looking information isinherently uncertain and actual results may differ materially from theassumptions, estimates or expectations reflected or contained in theforward-looking information, and that actual future performance will beaffected by a number of factors, including economic conditions, technologicalchange, regulatory change and competitive factors, many of which are beyond ourcontrol. Therefore, future events and results may vary significantly from whatwe currently foresee. We are under no obligation (and we expressly disclaim anysuch obligation) to update or alter the forward-looking statements whether as aresult of new information, future events or otherwise.Contact: Kevin Buckman MDViratech, Corp.http://viratech.orgEmail Contact: info@viratech.org   

test